23:29 EDT Cathie Wood’s ARK Investment buys 342K shares of 10x Genomics (TXG) today
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics price target lowered to $18 from $26 at Morgan Stanley
- 10x Genomics: Buy Rating Affirmed Amid Consumable Growth and Legal Resolutions
- Hold Rating Maintained for 10x Genomics Amid Settlement Gains and Macroeconomic Challenges
- 10x Genomics Settles Litigation with Bruker Corporation
- 10x Genomics announces patent litigation settlement with Bruker